Surgery for advanced pancreatic neuroendocrine tumors
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether surgically removing as much of the tumor as possible (debulking) is better than not doing surgery for people with advanced pancreatic neuroendocrine tumors. It aims to see if this approach can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a pancreatic neuroendocrine tumor (NET) that has spread to other parts of the body (stage 4).
- Your tumor is low- or medium-grade (grade 1 or 2), confirmed by a biopsy.
- You are at least 18 years old.
- You are able to have surgery and your medical team agrees it is safe.
- You have not had surgery for this tumor before.
- Your doctors can remove at least 70% of the total tumor volume based on scans.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether giving chemotherapy after surgery can lower cancer recurrence risk in people with high-risk pancreatic neuroendocrine tumors (NETs). It may help you by testing an added treatment after the tumor has been removed.
This trial tests if removing as much tumor as possible through surgery before a targeted radiation therapy (PRRT) can help people with well-differentiated neuroendocrine tumors that have spread to the liver. The goal is to see if this approach works better than radiation therapy alone.
This trial tests whether giving chemotherapy drugs (capecitabine and temozolomide) after surgery can help prevent pancreatic neuroendocrine tumors from coming back. You're eligible if your tumor was completely removed and shows intermediate to high risk of recurrence.
This trial uses a lab-grown model of your tumor (called an organoid) to test which drugs might work best for you. It is for people with advanced pancreatic neuroendocrine tumors who cannot have surgery.
This trial tests a minimally invasive endoscopic procedure that uses heat to treat certain pancreatic cysts (fluid-filled sacs) and small neuroendocrine tumors (hormone-producing growths). It may be an option if surgery isn't possible or if you prefer to avoid it.
This trial tests a procedure that uses an endoscope and ultrasound to heat (radiofrequency ablate) pancreatic neuroendocrine tumors. It may help shrink tumors while aiming to be a less invasive option.
Hear when a new Pancreatic Neuroendocrine Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.